Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

NCT03699254 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Transplantation Infection
Cytomegalovirus Infections

Interventions

DRUG: Valganciclovir
DRUG: Ganciclovir

Sponsor

Maimónides Biomedical Research Institute of Córdoba

Collaborators

[object Object]